Three African Countries Have Eliminated Malaria. What’s Stopping The Others? 05/10/2024 Maayan Hoffman Three African countries—Algeria, Cabo Verde, and Mauritius—have successfully eliminated malaria, but dozens more still face this deadly disease. Globally, only 44 countries have eradicated malaria. The question of whether the rest of Africa catch up was explored in the latest Global Health Matters podcast, hosted by Dr. Garry Aslanyan. To delve into this issue, Aslanyan […] Continue reading -> Gilead Urged to Expand Voluntary Licences for its Breakthrough HIV Treatment 03/10/2024 Kerry Cullinan HIV activists have hailed the announcement by Gilead on Wednesday that it has authorised six generic manufacturers to sell its breakthrough HIV treatment, lenacapavir, in 120 low- and middle-income countries. However, they have urged Gilead to expand the deal to include countries such as Brazil, Colombia and Mexico. Lenacapavir is a long-acting injectable drug that […] Continue reading -> WHO Revises RSV Vaccine Guidance; Africa Chalks Up Gains in Campaigns on HPV, Measles and ‘Zero-Dose’ Children 02/10/2024 Elaine Ruth Fletcher For the first time ever, the World Health Organization (WHO) has recommended that pregnant women be vaccinated against respiratory syncytial virus (RSV), or that their newborns receive a dose of monoclonal antibodies to protect them against severe RSV disease, which has seen a global resurgence as the COVID-19 pandemic waned. In 2022-2023, RSV was the […] Continue reading -> WHO’s mRNA Vaccine Hub Faces ‘Uncertainty and Structural Weaknesses’ 30/09/2024 Kerry Cullinan The establishment of an “mRNA hub” in South Africa to build the capacity of low- and middle-income countries (LMICs) to develop vaccines during the COVID-19 pandemic was widely hailed as a solution to Africa’s lack of manufacturing ability. But three years after its launch in June 2021, the hub faces uncertainties, risks and shortfalls – […] Continue reading -> World Leaders Approve Milestone Commitment to Reduce Deaths from Antibiotic Resistance by 10% by 2030 26/09/2024 Elaine Ruth Fletcher A UN High Level Meeting on Antimicrobial Resistance (AMR) pledged to reduce by 10% deaths from drug resistant bacteria over the next six years in a new declaration on the “silent, slow-motion pandemic” that could kill some 39 million more people by 2050. Thursday’s milestone statement, the first on the topic since 2016, also pledges […] Continue reading -> Investing in 24 Cents per Patient Annually in Digital Health Could Save 2 Million Lives 24/09/2024 Sophia Samantaroy Investing in as little as $0.24 per patient per year in digital health interventions – telemedicine, mobile messaging, and chatbots – could significantly lower the burden of non-communicable diseases (NCDs), says a new report from the World Health Organization (WHO) and the International Telecommunication Union (UTI). These interventions could avert 2 million deaths and 7 […] Continue reading -> Mpox and Cholera Outbreaks Underscore Importance of Gavi’s African Vaccine Initiative – But Can it Ensure Equity? 10/09/2024 Kerry Cullinan While COVID exposed the urgency of ensuring that Africa can manufacture vaccines, the current mpox and cholera outbreaks have painfully underscored the continent’s vulnerability. African countries affected by mpox are dependent on vaccine donations from wealthy countries, while a dire global shortage of cholera vaccines has forced the World Health Organization (WHO) to advise countries […] Continue reading -> More Countries Are Addressing AMR, But Many Reluctant to Commit to Specific Cut to Animal Antibiotic Use 03/09/2024 Kerry Cullinan While more countries are concerned about antimicrobial resistance (AMR) than a decade ago, many are reluctant to commit to a specific target to reduce the overuse of animal antibiotics as they negotiate a political declaration ahead of the United Nations high-level meeting on AMR. The zero draft of the declaration issued on 20 May proposed […] Continue reading -> The Global Response to Mpox: A Feeling of Déjà Vu? 23/08/2024 Janeen Madan Keller & Javier Guzman With the number of new mpox cases continuing to rise, and many more potentially undetected, African countries affected by the latest outbreak are racing to mobilize funds and urgently deploy medical countermeasures, including vaccines. But as the current epidemic unfolds, there is an undeniable feeling of déjà vu. Global efforts are falling short of what […] Continue reading -> Mpox Vaccine Manufacturing in Africa ‘Unlikely’, Donations as Most Likely Source, says Bavarian Nordic Official 15/08/2024 Elaine Ruth Fletcher Bavarian Nordic has no plans to sell or manufacture its vaccines directly to African countries, the company’s Vice President of Investor Relations told Health Policy Watch, saying that donations from rich countries will likely be the main source of supplies. WHO’s announcement of a global mpox health emergency may have sent a wake-up call to […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Gilead Urged to Expand Voluntary Licences for its Breakthrough HIV Treatment 03/10/2024 Kerry Cullinan HIV activists have hailed the announcement by Gilead on Wednesday that it has authorised six generic manufacturers to sell its breakthrough HIV treatment, lenacapavir, in 120 low- and middle-income countries. However, they have urged Gilead to expand the deal to include countries such as Brazil, Colombia and Mexico. Lenacapavir is a long-acting injectable drug that […] Continue reading -> WHO Revises RSV Vaccine Guidance; Africa Chalks Up Gains in Campaigns on HPV, Measles and ‘Zero-Dose’ Children 02/10/2024 Elaine Ruth Fletcher For the first time ever, the World Health Organization (WHO) has recommended that pregnant women be vaccinated against respiratory syncytial virus (RSV), or that their newborns receive a dose of monoclonal antibodies to protect them against severe RSV disease, which has seen a global resurgence as the COVID-19 pandemic waned. In 2022-2023, RSV was the […] Continue reading -> WHO’s mRNA Vaccine Hub Faces ‘Uncertainty and Structural Weaknesses’ 30/09/2024 Kerry Cullinan The establishment of an “mRNA hub” in South Africa to build the capacity of low- and middle-income countries (LMICs) to develop vaccines during the COVID-19 pandemic was widely hailed as a solution to Africa’s lack of manufacturing ability. But three years after its launch in June 2021, the hub faces uncertainties, risks and shortfalls – […] Continue reading -> World Leaders Approve Milestone Commitment to Reduce Deaths from Antibiotic Resistance by 10% by 2030 26/09/2024 Elaine Ruth Fletcher A UN High Level Meeting on Antimicrobial Resistance (AMR) pledged to reduce by 10% deaths from drug resistant bacteria over the next six years in a new declaration on the “silent, slow-motion pandemic” that could kill some 39 million more people by 2050. Thursday’s milestone statement, the first on the topic since 2016, also pledges […] Continue reading -> Investing in 24 Cents per Patient Annually in Digital Health Could Save 2 Million Lives 24/09/2024 Sophia Samantaroy Investing in as little as $0.24 per patient per year in digital health interventions – telemedicine, mobile messaging, and chatbots – could significantly lower the burden of non-communicable diseases (NCDs), says a new report from the World Health Organization (WHO) and the International Telecommunication Union (UTI). These interventions could avert 2 million deaths and 7 […] Continue reading -> Mpox and Cholera Outbreaks Underscore Importance of Gavi’s African Vaccine Initiative – But Can it Ensure Equity? 10/09/2024 Kerry Cullinan While COVID exposed the urgency of ensuring that Africa can manufacture vaccines, the current mpox and cholera outbreaks have painfully underscored the continent’s vulnerability. African countries affected by mpox are dependent on vaccine donations from wealthy countries, while a dire global shortage of cholera vaccines has forced the World Health Organization (WHO) to advise countries […] Continue reading -> More Countries Are Addressing AMR, But Many Reluctant to Commit to Specific Cut to Animal Antibiotic Use 03/09/2024 Kerry Cullinan While more countries are concerned about antimicrobial resistance (AMR) than a decade ago, many are reluctant to commit to a specific target to reduce the overuse of animal antibiotics as they negotiate a political declaration ahead of the United Nations high-level meeting on AMR. The zero draft of the declaration issued on 20 May proposed […] Continue reading -> The Global Response to Mpox: A Feeling of Déjà Vu? 23/08/2024 Janeen Madan Keller & Javier Guzman With the number of new mpox cases continuing to rise, and many more potentially undetected, African countries affected by the latest outbreak are racing to mobilize funds and urgently deploy medical countermeasures, including vaccines. But as the current epidemic unfolds, there is an undeniable feeling of déjà vu. Global efforts are falling short of what […] Continue reading -> Mpox Vaccine Manufacturing in Africa ‘Unlikely’, Donations as Most Likely Source, says Bavarian Nordic Official 15/08/2024 Elaine Ruth Fletcher Bavarian Nordic has no plans to sell or manufacture its vaccines directly to African countries, the company’s Vice President of Investor Relations told Health Policy Watch, saying that donations from rich countries will likely be the main source of supplies. WHO’s announcement of a global mpox health emergency may have sent a wake-up call to […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Revises RSV Vaccine Guidance; Africa Chalks Up Gains in Campaigns on HPV, Measles and ‘Zero-Dose’ Children 02/10/2024 Elaine Ruth Fletcher For the first time ever, the World Health Organization (WHO) has recommended that pregnant women be vaccinated against respiratory syncytial virus (RSV), or that their newborns receive a dose of monoclonal antibodies to protect them against severe RSV disease, which has seen a global resurgence as the COVID-19 pandemic waned. In 2022-2023, RSV was the […] Continue reading -> WHO’s mRNA Vaccine Hub Faces ‘Uncertainty and Structural Weaknesses’ 30/09/2024 Kerry Cullinan The establishment of an “mRNA hub” in South Africa to build the capacity of low- and middle-income countries (LMICs) to develop vaccines during the COVID-19 pandemic was widely hailed as a solution to Africa’s lack of manufacturing ability. But three years after its launch in June 2021, the hub faces uncertainties, risks and shortfalls – […] Continue reading -> World Leaders Approve Milestone Commitment to Reduce Deaths from Antibiotic Resistance by 10% by 2030 26/09/2024 Elaine Ruth Fletcher A UN High Level Meeting on Antimicrobial Resistance (AMR) pledged to reduce by 10% deaths from drug resistant bacteria over the next six years in a new declaration on the “silent, slow-motion pandemic” that could kill some 39 million more people by 2050. Thursday’s milestone statement, the first on the topic since 2016, also pledges […] Continue reading -> Investing in 24 Cents per Patient Annually in Digital Health Could Save 2 Million Lives 24/09/2024 Sophia Samantaroy Investing in as little as $0.24 per patient per year in digital health interventions – telemedicine, mobile messaging, and chatbots – could significantly lower the burden of non-communicable diseases (NCDs), says a new report from the World Health Organization (WHO) and the International Telecommunication Union (UTI). These interventions could avert 2 million deaths and 7 […] Continue reading -> Mpox and Cholera Outbreaks Underscore Importance of Gavi’s African Vaccine Initiative – But Can it Ensure Equity? 10/09/2024 Kerry Cullinan While COVID exposed the urgency of ensuring that Africa can manufacture vaccines, the current mpox and cholera outbreaks have painfully underscored the continent’s vulnerability. African countries affected by mpox are dependent on vaccine donations from wealthy countries, while a dire global shortage of cholera vaccines has forced the World Health Organization (WHO) to advise countries […] Continue reading -> More Countries Are Addressing AMR, But Many Reluctant to Commit to Specific Cut to Animal Antibiotic Use 03/09/2024 Kerry Cullinan While more countries are concerned about antimicrobial resistance (AMR) than a decade ago, many are reluctant to commit to a specific target to reduce the overuse of animal antibiotics as they negotiate a political declaration ahead of the United Nations high-level meeting on AMR. The zero draft of the declaration issued on 20 May proposed […] Continue reading -> The Global Response to Mpox: A Feeling of Déjà Vu? 23/08/2024 Janeen Madan Keller & Javier Guzman With the number of new mpox cases continuing to rise, and many more potentially undetected, African countries affected by the latest outbreak are racing to mobilize funds and urgently deploy medical countermeasures, including vaccines. But as the current epidemic unfolds, there is an undeniable feeling of déjà vu. Global efforts are falling short of what […] Continue reading -> Mpox Vaccine Manufacturing in Africa ‘Unlikely’, Donations as Most Likely Source, says Bavarian Nordic Official 15/08/2024 Elaine Ruth Fletcher Bavarian Nordic has no plans to sell or manufacture its vaccines directly to African countries, the company’s Vice President of Investor Relations told Health Policy Watch, saying that donations from rich countries will likely be the main source of supplies. WHO’s announcement of a global mpox health emergency may have sent a wake-up call to […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO’s mRNA Vaccine Hub Faces ‘Uncertainty and Structural Weaknesses’ 30/09/2024 Kerry Cullinan The establishment of an “mRNA hub” in South Africa to build the capacity of low- and middle-income countries (LMICs) to develop vaccines during the COVID-19 pandemic was widely hailed as a solution to Africa’s lack of manufacturing ability. But three years after its launch in June 2021, the hub faces uncertainties, risks and shortfalls – […] Continue reading -> World Leaders Approve Milestone Commitment to Reduce Deaths from Antibiotic Resistance by 10% by 2030 26/09/2024 Elaine Ruth Fletcher A UN High Level Meeting on Antimicrobial Resistance (AMR) pledged to reduce by 10% deaths from drug resistant bacteria over the next six years in a new declaration on the “silent, slow-motion pandemic” that could kill some 39 million more people by 2050. Thursday’s milestone statement, the first on the topic since 2016, also pledges […] Continue reading -> Investing in 24 Cents per Patient Annually in Digital Health Could Save 2 Million Lives 24/09/2024 Sophia Samantaroy Investing in as little as $0.24 per patient per year in digital health interventions – telemedicine, mobile messaging, and chatbots – could significantly lower the burden of non-communicable diseases (NCDs), says a new report from the World Health Organization (WHO) and the International Telecommunication Union (UTI). These interventions could avert 2 million deaths and 7 […] Continue reading -> Mpox and Cholera Outbreaks Underscore Importance of Gavi’s African Vaccine Initiative – But Can it Ensure Equity? 10/09/2024 Kerry Cullinan While COVID exposed the urgency of ensuring that Africa can manufacture vaccines, the current mpox and cholera outbreaks have painfully underscored the continent’s vulnerability. African countries affected by mpox are dependent on vaccine donations from wealthy countries, while a dire global shortage of cholera vaccines has forced the World Health Organization (WHO) to advise countries […] Continue reading -> More Countries Are Addressing AMR, But Many Reluctant to Commit to Specific Cut to Animal Antibiotic Use 03/09/2024 Kerry Cullinan While more countries are concerned about antimicrobial resistance (AMR) than a decade ago, many are reluctant to commit to a specific target to reduce the overuse of animal antibiotics as they negotiate a political declaration ahead of the United Nations high-level meeting on AMR. The zero draft of the declaration issued on 20 May proposed […] Continue reading -> The Global Response to Mpox: A Feeling of Déjà Vu? 23/08/2024 Janeen Madan Keller & Javier Guzman With the number of new mpox cases continuing to rise, and many more potentially undetected, African countries affected by the latest outbreak are racing to mobilize funds and urgently deploy medical countermeasures, including vaccines. But as the current epidemic unfolds, there is an undeniable feeling of déjà vu. Global efforts are falling short of what […] Continue reading -> Mpox Vaccine Manufacturing in Africa ‘Unlikely’, Donations as Most Likely Source, says Bavarian Nordic Official 15/08/2024 Elaine Ruth Fletcher Bavarian Nordic has no plans to sell or manufacture its vaccines directly to African countries, the company’s Vice President of Investor Relations told Health Policy Watch, saying that donations from rich countries will likely be the main source of supplies. WHO’s announcement of a global mpox health emergency may have sent a wake-up call to […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
World Leaders Approve Milestone Commitment to Reduce Deaths from Antibiotic Resistance by 10% by 2030 26/09/2024 Elaine Ruth Fletcher A UN High Level Meeting on Antimicrobial Resistance (AMR) pledged to reduce by 10% deaths from drug resistant bacteria over the next six years in a new declaration on the “silent, slow-motion pandemic” that could kill some 39 million more people by 2050. Thursday’s milestone statement, the first on the topic since 2016, also pledges […] Continue reading -> Investing in 24 Cents per Patient Annually in Digital Health Could Save 2 Million Lives 24/09/2024 Sophia Samantaroy Investing in as little as $0.24 per patient per year in digital health interventions – telemedicine, mobile messaging, and chatbots – could significantly lower the burden of non-communicable diseases (NCDs), says a new report from the World Health Organization (WHO) and the International Telecommunication Union (UTI). These interventions could avert 2 million deaths and 7 […] Continue reading -> Mpox and Cholera Outbreaks Underscore Importance of Gavi’s African Vaccine Initiative – But Can it Ensure Equity? 10/09/2024 Kerry Cullinan While COVID exposed the urgency of ensuring that Africa can manufacture vaccines, the current mpox and cholera outbreaks have painfully underscored the continent’s vulnerability. African countries affected by mpox are dependent on vaccine donations from wealthy countries, while a dire global shortage of cholera vaccines has forced the World Health Organization (WHO) to advise countries […] Continue reading -> More Countries Are Addressing AMR, But Many Reluctant to Commit to Specific Cut to Animal Antibiotic Use 03/09/2024 Kerry Cullinan While more countries are concerned about antimicrobial resistance (AMR) than a decade ago, many are reluctant to commit to a specific target to reduce the overuse of animal antibiotics as they negotiate a political declaration ahead of the United Nations high-level meeting on AMR. The zero draft of the declaration issued on 20 May proposed […] Continue reading -> The Global Response to Mpox: A Feeling of Déjà Vu? 23/08/2024 Janeen Madan Keller & Javier Guzman With the number of new mpox cases continuing to rise, and many more potentially undetected, African countries affected by the latest outbreak are racing to mobilize funds and urgently deploy medical countermeasures, including vaccines. But as the current epidemic unfolds, there is an undeniable feeling of déjà vu. Global efforts are falling short of what […] Continue reading -> Mpox Vaccine Manufacturing in Africa ‘Unlikely’, Donations as Most Likely Source, says Bavarian Nordic Official 15/08/2024 Elaine Ruth Fletcher Bavarian Nordic has no plans to sell or manufacture its vaccines directly to African countries, the company’s Vice President of Investor Relations told Health Policy Watch, saying that donations from rich countries will likely be the main source of supplies. WHO’s announcement of a global mpox health emergency may have sent a wake-up call to […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Investing in 24 Cents per Patient Annually in Digital Health Could Save 2 Million Lives 24/09/2024 Sophia Samantaroy Investing in as little as $0.24 per patient per year in digital health interventions – telemedicine, mobile messaging, and chatbots – could significantly lower the burden of non-communicable diseases (NCDs), says a new report from the World Health Organization (WHO) and the International Telecommunication Union (UTI). These interventions could avert 2 million deaths and 7 […] Continue reading -> Mpox and Cholera Outbreaks Underscore Importance of Gavi’s African Vaccine Initiative – But Can it Ensure Equity? 10/09/2024 Kerry Cullinan While COVID exposed the urgency of ensuring that Africa can manufacture vaccines, the current mpox and cholera outbreaks have painfully underscored the continent’s vulnerability. African countries affected by mpox are dependent on vaccine donations from wealthy countries, while a dire global shortage of cholera vaccines has forced the World Health Organization (WHO) to advise countries […] Continue reading -> More Countries Are Addressing AMR, But Many Reluctant to Commit to Specific Cut to Animal Antibiotic Use 03/09/2024 Kerry Cullinan While more countries are concerned about antimicrobial resistance (AMR) than a decade ago, many are reluctant to commit to a specific target to reduce the overuse of animal antibiotics as they negotiate a political declaration ahead of the United Nations high-level meeting on AMR. The zero draft of the declaration issued on 20 May proposed […] Continue reading -> The Global Response to Mpox: A Feeling of Déjà Vu? 23/08/2024 Janeen Madan Keller & Javier Guzman With the number of new mpox cases continuing to rise, and many more potentially undetected, African countries affected by the latest outbreak are racing to mobilize funds and urgently deploy medical countermeasures, including vaccines. But as the current epidemic unfolds, there is an undeniable feeling of déjà vu. Global efforts are falling short of what […] Continue reading -> Mpox Vaccine Manufacturing in Africa ‘Unlikely’, Donations as Most Likely Source, says Bavarian Nordic Official 15/08/2024 Elaine Ruth Fletcher Bavarian Nordic has no plans to sell or manufacture its vaccines directly to African countries, the company’s Vice President of Investor Relations told Health Policy Watch, saying that donations from rich countries will likely be the main source of supplies. WHO’s announcement of a global mpox health emergency may have sent a wake-up call to […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Mpox and Cholera Outbreaks Underscore Importance of Gavi’s African Vaccine Initiative – But Can it Ensure Equity? 10/09/2024 Kerry Cullinan While COVID exposed the urgency of ensuring that Africa can manufacture vaccines, the current mpox and cholera outbreaks have painfully underscored the continent’s vulnerability. African countries affected by mpox are dependent on vaccine donations from wealthy countries, while a dire global shortage of cholera vaccines has forced the World Health Organization (WHO) to advise countries […] Continue reading -> More Countries Are Addressing AMR, But Many Reluctant to Commit to Specific Cut to Animal Antibiotic Use 03/09/2024 Kerry Cullinan While more countries are concerned about antimicrobial resistance (AMR) than a decade ago, many are reluctant to commit to a specific target to reduce the overuse of animal antibiotics as they negotiate a political declaration ahead of the United Nations high-level meeting on AMR. The zero draft of the declaration issued on 20 May proposed […] Continue reading -> The Global Response to Mpox: A Feeling of Déjà Vu? 23/08/2024 Janeen Madan Keller & Javier Guzman With the number of new mpox cases continuing to rise, and many more potentially undetected, African countries affected by the latest outbreak are racing to mobilize funds and urgently deploy medical countermeasures, including vaccines. But as the current epidemic unfolds, there is an undeniable feeling of déjà vu. Global efforts are falling short of what […] Continue reading -> Mpox Vaccine Manufacturing in Africa ‘Unlikely’, Donations as Most Likely Source, says Bavarian Nordic Official 15/08/2024 Elaine Ruth Fletcher Bavarian Nordic has no plans to sell or manufacture its vaccines directly to African countries, the company’s Vice President of Investor Relations told Health Policy Watch, saying that donations from rich countries will likely be the main source of supplies. WHO’s announcement of a global mpox health emergency may have sent a wake-up call to […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
More Countries Are Addressing AMR, But Many Reluctant to Commit to Specific Cut to Animal Antibiotic Use 03/09/2024 Kerry Cullinan While more countries are concerned about antimicrobial resistance (AMR) than a decade ago, many are reluctant to commit to a specific target to reduce the overuse of animal antibiotics as they negotiate a political declaration ahead of the United Nations high-level meeting on AMR. The zero draft of the declaration issued on 20 May proposed […] Continue reading -> The Global Response to Mpox: A Feeling of Déjà Vu? 23/08/2024 Janeen Madan Keller & Javier Guzman With the number of new mpox cases continuing to rise, and many more potentially undetected, African countries affected by the latest outbreak are racing to mobilize funds and urgently deploy medical countermeasures, including vaccines. But as the current epidemic unfolds, there is an undeniable feeling of déjà vu. Global efforts are falling short of what […] Continue reading -> Mpox Vaccine Manufacturing in Africa ‘Unlikely’, Donations as Most Likely Source, says Bavarian Nordic Official 15/08/2024 Elaine Ruth Fletcher Bavarian Nordic has no plans to sell or manufacture its vaccines directly to African countries, the company’s Vice President of Investor Relations told Health Policy Watch, saying that donations from rich countries will likely be the main source of supplies. WHO’s announcement of a global mpox health emergency may have sent a wake-up call to […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
The Global Response to Mpox: A Feeling of Déjà Vu? 23/08/2024 Janeen Madan Keller & Javier Guzman With the number of new mpox cases continuing to rise, and many more potentially undetected, African countries affected by the latest outbreak are racing to mobilize funds and urgently deploy medical countermeasures, including vaccines. But as the current epidemic unfolds, there is an undeniable feeling of déjà vu. Global efforts are falling short of what […] Continue reading -> Mpox Vaccine Manufacturing in Africa ‘Unlikely’, Donations as Most Likely Source, says Bavarian Nordic Official 15/08/2024 Elaine Ruth Fletcher Bavarian Nordic has no plans to sell or manufacture its vaccines directly to African countries, the company’s Vice President of Investor Relations told Health Policy Watch, saying that donations from rich countries will likely be the main source of supplies. WHO’s announcement of a global mpox health emergency may have sent a wake-up call to […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Mpox Vaccine Manufacturing in Africa ‘Unlikely’, Donations as Most Likely Source, says Bavarian Nordic Official 15/08/2024 Elaine Ruth Fletcher Bavarian Nordic has no plans to sell or manufacture its vaccines directly to African countries, the company’s Vice President of Investor Relations told Health Policy Watch, saying that donations from rich countries will likely be the main source of supplies. WHO’s announcement of a global mpox health emergency may have sent a wake-up call to […] Continue reading -> Posts navigation Older posts